Polyp Clinical Trials

177 recruitingLast updated: June 18, 2026

There are 177 actively recruiting polyp clinical trials across 45 countries. Studies span Not Applicable, Phase 3, Phase 2, Phase 4, Phase 1, Early Phase 1. Top locations include Chicago, Illinois, United States, Houston, Texas, United States, Montreal, Quebec, Canada. Updated daily from ClinicalTrials.gov.


Polyp Trials at a Glance

177 actively recruiting trials for polyp are listed on ClinicalTrialsFinder across 6 cities in 45 countries. The largest study group is Not Applicable with 65 trials, with the heaviest enrollment activity in Chicago, Houston, and Montreal. Lead sponsors running polyp studies include Centre hospitalier de l'Université de Montréal (CHUM), AstraZeneca, and Chinese University of Hong Kong.

Treatments under study

About Polyp Clinical Trials

Looking for clinical trials for Polyp? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Polyp trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Polyp clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 177 trials

Recruiting

Familial Investigations of Childhood Cancer Predisposition

Pancreatic CancerHereditary Breast and Ovarian CancerHodgkin Lymphoma+43 more
St. Jude Children's Research Hospital1,500 enrolled1 locationNCT03050268
Recruiting

Early Detection of Advanced Adenomas and Colorectal Cancer

Colorectal, CancerColorectal NeoplasmsColorectal Adenocarcinoma+15 more
City of Hope Medical Center2,000 enrolled6 locationsNCT06342440
Recruiting

A Study of a Urine Test to Detect Colorectal Cancer

Rectal bleedingColorectal, CancerCRC+1 more
Memorial Sloan Kettering Cancer Center210 enrolled4 locationsNCT07649057
Recruiting
Phase 1

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Colorectal CarcinomaFamilial Adenomatous PolyposisColorectal Adenomatous Polyp+1 more
National Cancer Institute (NCI)36 enrolled5 locationsNCT05630794
Recruiting

A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients

Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca200 enrolled16 locationsNCT07446738
Recruiting
Not Applicable

Testing of GripTract-GI Endoscopic Tissue Manipulator for Use During Complex Endoscopic Polypectomies in the Colon

Polyps Colorectal
Actuated Medical, Inc.30 enrolled1 locationNCT06015607
Recruiting
Phase 4

Biologics in Chronic Rhinosinusitis With Nasal Polyposis

Chronic SinusitisNasal Polyps
Medical University of South Carolina504 enrolled1 locationNCT06824649
Recruiting
Phase 1Phase 2

Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

Familial Adenomatous Polyposis
Recursion Pharmaceuticals Inc.67 enrolled17 locationsNCT05552755
Recruiting
Phase 3

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Eli Lilly and Company510 enrolled194 locationsNCT06338995
Recruiting

ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia

AsthmaChronic Rhinosinusitis With Nasal Polyps (CRSwNP)
AstraZeneca110 enrolled11 locationsNCT07399665
Recruiting
Not Applicable

Exploration of Potential Biomarkers of Polyphenol Intake From Artichoke By-product Supplements

healthy adult participantsADMEPolyphenols Absorption Profile+1 more
Iziar Amaia Ludwig Sanz Orrio16 enrolled1 locationNCT07615673
Recruiting
Phase 3

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Familial Adenomatous Polyposis (FAP)
Rapamycin Holdings Inc.168 enrolled29 locationsNCT06950385
Recruiting

Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)

Familial Adenomatous Polyposis
Hospices Civils de Lyon100 enrolled2 locationsNCT06614738
Recruiting
Phase 3

A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca230 enrolled1 locationNCT07520162
Recruiting
Not Applicable

3D Printing to Improve Nasal Irrigation Outcome

Chronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis Without Nasal Polyps
Ohio State University200 enrolled1 locationNCT06118554
Recruiting
Phase 3

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled112 locationsNCT06834360
Recruiting
Not Applicable

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

Familial Adenomatous Polyposis
University of Michigan Rogel Cancer Center32 enrolled2 locationsNCT06641310
Recruiting
Not Applicable

BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry

Nasal PolypsRhinosinusitis Chronic
University Hospital, Lille900 enrolled2 locationsNCT06501807
Recruiting

St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)

Colon AdenomaColon PolypColon Lesion
University of British Columbia3,500 enrolled6 locationsNCT05402696
Recruiting
Phase 2

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Colorectal CarcinomaFamilial Adenomatous Polyposis
National Cancer Institute (NCI)38 enrolled4 locationsNCT06557733